蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1687|回复: 7
收起左侧

[GMP相关] keep running

[复制链接]
药士
发表于 2016-11-2 23:02:51 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x

The Risk of Biofilm

  
Because of the high microbiological requirements on water for pharmaceutical use and the high risks linked to a microbiological water contamination, enormous efforts are taken in the pharmaceutical industry to prevent from bacterial growth in water systems. Such systems are normally composed of the water treatment as well as the storage and distribution system.
The dangers arising from biofilms are hereby often underestimated.
Sanitisation measures are often directed to (aquatic) bacteria. Those bacteria reach the high-purity - and thus nutrient-poor - waters of the pharmaceutical industry, but only to an insignificant extent. For energy reasons, a small concentration of nutrients coming from the feed water can form deposits on the inner surfaces of piping system for example. Those surfaces are also a promising location for bacteria to settle and proliferate. An additional favourable factor for that settlement and proliferation of bacteria is the low flow rate on the surfaces of the pipes, which even tends to be inexistent in laminar flows. Therefore, without any mechanical action, a flow washing of the bacteria can't be expected. Bacteria in formatting biofilms behave differently than in a free state. This leads to the formation of layers containing polysaccharide which overlie the bacteria of the biofilm as a protector.
Within this protection layer, the bacteria are characterised by a very much higher tolerance to heat, disinfectants and dehydration than in a free (aquatic) state. This is a reason why bacteria in biofilms can survive sanitisation measures. Even if all cells within a film are killed, the cell-polysaccharide-compound remaining on the surface offers an ideal breeding ground for other bacteria which may come isolated from the feed water into the water system. This means that both living and dead biofilms present a risk for the pharmaceutical finished product. On the one hand, living bacteria or parts of the biofilm compound keep on detaching again and again and thus present a microbiological source of contamination for other parts of the system.  On the other hand, killed-off biofilm fragments constitute a source of contamination with endotoxins.
That's why the fight against biofilms is and remains a challenge for the pharmaceutical industry. It is essential to set appropriate measures for the water system (biofilm management) and to implement them consistently - for example hot storage, sanitisation with steam or ozone. Therefore, as early as the planning phase it is necessary to establish an appropriate design of the system counteracting the formation of biofilms - e.g. preventing from dead-legs or low points that cannot be emptied. Yet, the system operating is as essential as the design. Downtimes always present a higher risk of microbial growth. An uncontrolled weekend is already sufficient to lead to a significant bacterial contamination. "Keep the system running" is thus the best protection of a well-designed water system.


回复

使用道具 举报

药士
 楼主| 发表于 2016-11-2 23:44:54 | 显示全部楼层
我这一篇自动删除!请看娇姐翻译!主要是我不懂中文,怕翻译不好!
回复

使用道具 举报

药士
发表于 2016-11-3 00:22:46 | 显示全部楼层
什么情况?
回复

使用道具 举报

药徒
发表于 2016-11-3 06:17:09 | 显示全部楼层
好吧,Keep going!
回复

使用道具 举报

发表于 2016-11-3 08:38:25 | 显示全部楼层
请翻译成中文!

点评

流水不腐,水系统始终保持循环以降低生物膜的生长以及生物污染的风险  详情 回复 发表于 2016-11-3 08:44
回复

使用道具 举报

药徒
发表于 2016-11-3 08:44:16 | 显示全部楼层

流水不腐,水系统始终保持循环以降低生物膜的生长以及生物污染的风险

点评

厉害  详情 回复 发表于 2016-11-3 09:45
回复

使用道具 举报

药徒
发表于 2016-11-3 09:45:17 | 显示全部楼层
2-304陈勇军 发表于 2016-11-3 08:44
流水不腐,水系统始终保持循环以降低生物膜的生长以及生物污染的风险

厉害
回复

使用道具 举报

药王
发表于 2023-2-22 22:08:50 | 显示全部楼层
谢谢分享。
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-7-21 18:21

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表